Duke Symposium Showcases Diverse Obesity Research, Patient Experiences
The symposium convened multiple Duke obesity experts, community members, and patients to discuss current knowledge, challenges, and future opportunities.
DCRI Researchers Weigh In On Patient Data-Sharing
The paper outlines potential benefits and challenges for adopting initiatives that would enable data sharing at an individual patient level.
Warfarin Control Measures May Not Accurately Predict Risk in Atrial Fibrillation Patients
The study results suggest that clinical factors may be more useful than international normalized ratio metrics in predicting future risk of bleeding or thrombotic events.
Medical Misinformation Causes Underuse of Statins
The DCRI’s Ann Marie Navar, MD, PhD, writes that medical misinformation surrounding statins is causing patients to stop or avoid statins, missing out on a major opportunity to prevent heart at
The DCRI Welcomes Three Former Fellows As New Faculty
The new faculty represent the pediatrics, nephrology, and musculoskeletal therapeutic areas.
ARLG Study Employs Innovative Model to Test Diagnostics for Extragenital Gonorrhea
The study’s design, which researchers hope to use for other conditions, enabled testing of multiple diagnostic assays simultaneously and resulted in cost savings.
ARLG Study Employs Innovative Model to Test Diagnostics for Extragenital Gonorrhea
The study’s design, which researchers hope to use for other conditions, enabled testing of multiple diagnostic assays simultaneously and resulted in cost savings.
DCRI Contributes to AHA Statement on HIV and Cardiovascular Disease
The statement suggests that when treating people living with HIV who exhibit certain characteristics, clinicians should multiply conventional risk calculator scores by 1.5 to 2.
DCRI Co-Hosts Youth Tobacco Cessation Workshop at FDA
The event drew nearly 900 registrants and discussed tobacco-cessation therapies that have been successful in youth populations, as well as gaps in knowledge surrounding e-cigarettes.
Data Suggest Results From FDA-Mandated Testing Often Not Implemented in Clinical Practice
Investigators were unsure how they would use genetic information to choose treatment choices, then often failed to follow through on their pre-stipulated plan to use this information.